AAAAAA
Results:
1-7
|
Results: 7
Authors:
Ruilope, LM
Aldigier, JC
Ponticelli, C
Oddou-Stock, P
Botteri, F
Mann, JF
Citation: Lm. Ruilope et al., Safety of the combination of valsartan and benazepril in patients with chronic renal disease, J HYPERTENS, 18(1), 2000, pp. 89-95
Authors:
Cheung, R
Lewanczuk, RZ
Rodger, NW
Huff, MW
Oddou-Stock, P
Botteri, F
Pecher, E
Muirhead, N
Citation: R. Cheung et al., The effect of valsartan and captopril on lipid parameters in patients withtype II diabetes mellitus and nephropathy, INT J CL PR, 53(8), 1999, pp. 584
Authors:
Hedner, T
Oparil, S
Rasmussen, K
Rapelli, A
Gatlin, M
Kobi, P
Sullivan, J
Oddou-Stock, P
Citation: T. Hedner et al., A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension, AM J HYPERT, 12(4), 1999, pp. 414-417
Authors:
Lee, CM
Lee, YT
Lang, MG
Thirlwell, J
Oddou-Stock, P
Citation: Cm. Lee et al., A comparison of valsartan and captopril in Taiwanese patients with essential hypertension, ADV THER, 16(1), 1999, pp. 39-48
Authors:
Faulhaber, HD
Mann, JF
Stein, G
Jansa, U
Oddou-Stock, P
Spormann, D
Heath, R
Klingl, KG
Bodin, F
Luft, FC
Citation: Hd. Faulhaber et al., Effect of valsartan on renal function in patients with hypertension and stable renal insufficiency, CURR THER R, 60(3), 1999, pp. 170-183
Authors:
Muirhead, N
Feagan, BF
Mahon, J
Lewanczuk, RZ
Rodger, NW
Botteri, F
Oddou-Stock, P
Pecher, E
Cheung, R
Citation: N. Muirhead et al., The effects of valsartan and captopril on reducing microalbuminuria in patients with type 2 diabetes mellitus: A placebo-controlled trial, CURR THER R, 60(12), 1999, pp. 650-660
Authors:
Pool, J
Oparil, S
Hedner, T
Glazer, R
Oddou-Stock, P
Hester, A
Citation: J. Pool et al., Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker, CLIN THER, 20(6), 1998, pp. 1106-1114
Risultati:
1-7
|